Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Common Equity (2023 - 2025)

Historic Common Equity for Baird Medical Investment Holdings (BDMD) over the last 3 years, with Q2 2025 value amounting to $35.6 million.

  • Baird Medical Investment Holdings' Common Equity changed N/A to $35.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $35.6 million, marking a year-over-year change of. This contributed to the annual value of $39.8 million for FY2024, which is 1121.61% up from last year.
  • Latest data reveals that Baird Medical Investment Holdings reported Common Equity of $35.6 million as of Q2 2025.
  • In the past 5 years, Baird Medical Investment Holdings' Common Equity registered a high of $39.8 million during Q4 2024, and its lowest value of $35.6 million during Q2 2025.
  • Moreover, its 3-year median value for Common Equity was $35.8 million (2023), whereas its average is $37.0 million.
  • Data for Baird Medical Investment Holdings' Common Equity shows a peak YoY increase of 1121.61% (in 2024) and a maximum YoY decrease of 1121.61% (in 2024) over the last 5 years.
  • Over the past 3 years, Baird Medical Investment Holdings' Common Equity (Quarter) stood at $35.8 million in 2023, then increased by 11.22% to $39.8 million in 2024, then decreased by 10.4% to $35.6 million in 2025.
  • Its last three reported values are $35.6 million in Q2 2025, $39.8 million for Q4 2024, and $35.8 million during Q4 2023.